United States · FDA National Drug Code directory
oxcarbazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1843_a783b6fe-6bb8-4684-a7a5-107288a969ab
- Product NDC
- 70771-1843
- Form
- TABLET
- Composition / generic term
- oxcarbazepine
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250710
- Source listing expiry
- 20271231
Source-listed ingredients
- OXCARBAZEPINE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (70771-1843-0) · 70771-1843-0
- 100 TABLET in 1 BOTTLE (70771-1843-1) · 70771-1843-1
- 10 BLISTER PACK in 1 CARTON (70771-1843-4) / 10 TABLET in 1 BLISTER PACK · 70771-1843-4
- 500 TABLET in 1 BOTTLE (70771-1843-5) · 70771-1843-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →